Scarica l'app Stockscreener
4.22
1.69%
0.07
Precedente Chiudi:
$4.15
Aprire:
$4.15
Volume 24 ore:
44,232
Relative Volume:
0.11
Capitalizzazione di mercato:
$4.02M
Reddito:
$9.93M
Utile/perdita netta:
$-11.10M
Rapporto P/E:
-3.376
EPS:
-1.25
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
-8.46%
1M Prestazione:
-10.78%
6M Prestazione:
-31.47%
1 anno Prestazione:
-62.74%
Intervallo 1D:
$3.94
$4.35
Intervallo di 1 settimana:
$3.94
$4.84
Portata 52W:
$3.41
$12.59
Ispecimen Inc Stock (ISPC) Company Profile
Nome
Ispecimen Inc
Settore
Industria
Telefono
781-301-6700
Indirizzo
8 CABOT ROAD, WOBURN
Confronta ISPC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
4.22 | 4.02M | 9.93M | -11.10M | -10.55M | -1.25 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Ispecimen Inc Borsa (ISPC) Ultime notizie
ISpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - Marketscreener.com
Bernstein: 'Welcome to the crypto bull marketBuy everything you can' - Investing.com
iSpecimen Inc. Reports Earnings Amid Financial Challenges - TipRanks
iSpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - The Globe and Mail
iSpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - The Globe and Mail
E.L.F. Beauty Inc (ELF-N) QuotePress Release - The Globe and Mail
ISpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - Marketscreener.com
iSpecimen Inc. Stocks 48% Premarket Surge On Thursday Ignited A Regular Session Rally - The Globe and Mail
iSpecimen Emerges as Key Player in $13.5B Biospecimen Market, Shows 13.3% Growth Potential | ISPC Stock News - StockTitan
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - The Manila Times
iSpecimen Expands Cancer Sample Database, Projects $10M Annual Orders & 20% Growth | ISPC Stock News - StockTitan
iSpecimen Reports Third Quarter 2024 Results - The Manila Times
iSpecimen Q3 Revenue Dips Despite Cost-Cutting Push; Net Loss Narrows 32% | ISPC Stock News - StockTitan
Coinbase Global Inc Cl A (COIN-Q) QuotePress Release - The Globe and Mail
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
iSpecimen Announces Public Offering to Support Growth - TipRanks
ISpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Marketscreener.com
iSpecimen stock hits 52-week low at $3.41 amid market challenges By Investing.com - Investing.com South Africa
iSpecimen stock hits 52-week low at $3.41 amid market challenges - Investing.com
iSpecimen announces pricing of $5M public offering - TipRanks
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - ForexTV.com
ISPCiSpecimen Inc. Latest Stock News & Market Updates - StockTitan
iSpecimen sets $5 million public stock offering at $3 per share - Investing.com
TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail
Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Decreases By 86.9% - MarketBeat
Whirlpool Corp (WHR-N) QuotePress Release - The Globe and Mail
Canacol Energy Ltd (CNNEF) QuotePress Release - The Globe and Mail
Specimen Validity Testing Market Report 2024Specimen - openPR
Brinker International (EAT-N) QuotePress Release - The Globe and Mail
iSpecimen Inc. (NASDAQ:ISPC) Sees Significant Increase in Short Interest - MarketBeat
How to Take Advantage of moves in (ISPC) - Stock Traders Daily
iSpecimen Regains Nasdaq compliance, faces arbitration claim By Investing.com - Investing.com South Africa
iSpecimen Regains Nasdaq compliance, faces arbitration claim - Investing.com India
iSpecimen Faces Ex-Executive’s Financial Claims, Regains Nasdaq Compliance - TipRanks
Trend Tracker for (ISPC) - Stock Traders Daily
iSpecimen secures $1M loan, appoints three board members - TipRanks
iSpecimen secures $1 million loan, revamps board - Investing.com
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members - citybiz
ISpecimen Inc. Announces Board Changes - Marketscreener.com
iSpecimen Bolsters Finance with Loan and Board Revamp - TipRanks
ISPC Stock: Exploring iSpecimen Inc’s Growth - The InvestChronicle
iSpecimen Inc. (NASDAQ:ISPC) Short Interest Down 8.3% in August - MarketBeat
Investing in iSpecimen Inc (ISPC) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Ratio Revelations: iSpecimen Inc (ISPC)’s Financial Metrics in the Spotlight - The Dwinnex
ISPC Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Ispecimen Inc Azioni (ISPC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):